Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
Price:
22.41
USD
2.89%
Market Closed
Market Cap:
$2.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ultragenyx Pharmaceutical Inc
NASDAQ:RARE
|
US |
Wall St Price Targets
RARE Price Targets Summary
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc
Wall Street analysts forecast RARE stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RARE is 52.72 USD with a low forecast of 25.25 USD and a high forecast of 88.2 USD.
Lowest Forecast
Price Target
25.25
USD
13% Upside
Average Forecast
Price Target
52.72
USD
135% Upside
Highest Forecast
Price Target
88.2
USD
294% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RARE's stock price target?
Price Target
52.72
USD
52.72
USD
According to Wall Street analysts, the average 1-year price target for RARE is 52.72 USD with a low forecast of 25.25 USD and a high forecast of 88.2 USD.
What is the Revenue forecast for Ultragenyx Pharmaceutical Inc?
Projected CAGR
23%
23%
The compound annual growth rate for Revenue over the next 8 years is 23%.
